Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0369820130430050353
Jorunal of Korean Pharmaceutical Sciences
2013 Volume.43 No. 5 p.353 ~ p.362
Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs): recent advances in drug delivery
Yoon Goo

Park Jin-Woo
Yoon In-Soo
Abstract
Solid lipid-based nanoparticles (SLBNs) were developed as potential alternatives to other conventional drug delivery systems such as polymeric nanoparticles, liposomes, and emulsions. In general, SLBNs are divided into two types: solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs). SLNs are distinguishable from NLCs by the composition of solid particle matrix. SLBNs can be prepared by several methods including high pressure homogenization, solvent emulsification (or diffusion)-evaporation, and microemulsion technologies. Then, SLBNs can be characterized in terms of particle size distribution, surface charge, morphology, and crystallinity. SLBNs are well-tolerated and efficient carrier systems for parenteral, oral, inhalational, ocular, and dermal applications. This review provides an overview of the preparation and characterization technologies for SLBNs and focuses on recent advances in drug delivery using SLBNs.
KEYWORD
Solid lipid-based nanoparticles (SLBNs), Solid lipid nanoparticles (SLNs), Nanostructured lipid carriers (NLCs), Drug delivery
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI)